Optimization of continuous infusion of piperacillin-tazobactam in children with fever and neutropenia
- PMID: 23629023
- DOI: 10.1097/INF.0b013e318298dfb8
Optimization of continuous infusion of piperacillin-tazobactam in children with fever and neutropenia
Abstract
The study through Monte Carlo simulation of β-lactam pharmacokinetic/pharmacodynamic target attainment and determination of subsequent serum concentrations of piperacillin-tazobactam administered through continuous infusion to children treated for fever and neutropenia shows that 400 mg/kg/day has the highest probability of target attainment against Pseudomonas aeurginosa in our oncology ward compared with the standard regimen of 300 mg/kg/day.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical